These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1381012)

  • 21. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
    Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B
    Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
    Tapp RJ; Sharp A; Stanton AV; O'Brien E; Chaturvedi N; Poulter NR; Sever PS; Thom SA; Hughes AD; Mayet J;
    J Am Coll Cardiol; 2010 Apr; 55(17):1875-81. PubMed ID: 20413040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension.
    Zusman RM; Christensen DM; Federman EB; Ruddy TD; Miller DD; Boucher CA
    Am J Cardiol; 1989 Sep; 64(11):51F-61F. PubMed ID: 2782271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of left ventricular diastolic filling in hypertensive patients: effects of nitrendipine and atenolol.
    De Kock M; Melin JA; Nannan ME; Robert A; Beckers C; Lavenne F; Detry JM
    Eur Heart J; 1986 Sep; 7(9):792-9. PubMed ID: 3769959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM; Madkour MA; Mossallam R
    Circulation; 1980 Nov; 62(5):1036-45. PubMed ID: 7418154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.
    Samuelsson O; Hedner T; Ljungman S; Herlitz H; Widgren B; Pennert K
    Eur J Clin Pharmacol; 1992; 43(5):469-75. PubMed ID: 1336463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.
    Agarwal R; Sinha AD; Pappas MK; Abraham TN; Tegegne GG
    Nephrol Dial Transplant; 2014 Mar; 29(3):672-81. PubMed ID: 24398888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
    Laufer E; Reid C; Qi XL; Jennings GL
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
    Cholley BP; Shroff SG; Sandelski J; Korcarz C; Balasia BA; Jain S; Berger DS; Murphy MB; Marcus RH; Lang RM
    Circulation; 1995 Feb; 91(4):1052-62. PubMed ID: 7850941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
    Georgianos PI; Agarwal R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):639-45. PubMed ID: 25784174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of left ventricular function by radionuclide ventriculogram in hypertensive patients treated with atenolol.
    Marcó EJ; Otero F; Dopico AM; Ramírez AJ; Degrossi O; Sánchez RA
    Medicina (B Aires); 1990; 50(6):518-20. PubMed ID: 2130241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
    Beltman F; Heesen W; Smit A; May J; de Graeff P; Havinga T; Schuurman F; van der Veur E; Lie K; Meyboom-de Jong B
    J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of atenolol versus bisoprolol with noninvasive hemodynamic and pulse wave assessment.
    Aparicio LS; Alfie J; Barochiner J; Cuffaro PE; Giunta DH; Elizondo CM; Tortella JJ; Morales MS; Rada MA; Waisman GD
    J Am Soc Hypertens; 2015 May; 9(5):390-6. PubMed ID: 25816713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Regulatory-adaptive abilities of hypertensive patients treated with lisinopril and atenolol].
    Ter Arkh; 2005; 77(3):69-71. PubMed ID: 15881105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.